Gossamer Bio, Inc. (GOSS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.18-0.17%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GOSS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 53.3 | 48.5 | 114.7 | 0.0 | 0.0 | — | — | — |
| Operating Expenses & Income | ||||||||
| Operating Income | (166.1) | (170.7) | (59.9) | (183.8) | (218.6) | (216.1) | (234.0) | (186.1) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | 11.0 | 11.5 | 13.5 | 13.9 | 19.4 | 12.7 | — |
| Interest & Investment Income | 1.8 | 2.0 | 1.8 | 2.0 | 1.6 | 0.8 | — | — |
| Net Interest Expenses | — | — | — | 11.5 | 12.3 | 18.7 | — | — |
| Other Non-Operating Income / Expenses | 40.8 | 0.3 | 4.3 | 3.9 | (10.8) | (17.9) | — | 5.8 |
| EBT, Incl. Unusual Items | — | (170.5) | (55.6) | (179.8) | (229.4) | (234.0) | (243.4) | (180.3) |
| Income Tax Expense | — | (0.1) | 0.9 | 0.0 | 0.0 | — | — | 0.0 |
| Net Income | ||||||||
| Net Income | (125.2) | (170.4) | (56.5) | (179.8) | (229.4) | (234.0) | (243.4) | (180.3) |
| Per Share | ||||||||
| Basic EPS | (0.39) | (0.75) | (0.25) | (1.18) | (2.71) | (3.13) | (3.55) | — |
| Diluted EPS | (0.38) | (0.75) | (0.25) | (1.18) | (2.71) | (3.13) | (3.55) | — |
| Revenue per Share | 0.16 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 320.0 | 228.5 | 226.2 | 152.6 | 84.6 | 74.8 | 68.5 | — |
| Diluted Weighted Avg Shares | 328.8 | 228.5 | 226.2 | 152.6 | 84.6 | 74.8 | 68.5 | — |
| Supplemental | ||||||||
| EBITDA | — | (170.7) | (59.1) | (182.2) | (216.8) | (214.4) | (232.6) | (185.2) |
| EBIT | (166.1) | (170.7) | (59.9) | (183.8) | (218.6) | (216.1) | (234.0) | (186.1) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | — | — | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.